Abstract:Milk-derived extracellular vesicles (mEVs) are emerging as promising therapeutic candidates due to their unique properties and versatile functions. These vesicles play a crucial role in immunomodulation by influencing macrophage differentiation and cytokine production, potentially aiding in the treatment of conditions such as bone loss, fibrosis, and cancer. mEVs also have the capacity to modulate gut microbiota composition, which may alleviate the symptoms of inflammatory bowel diseases and promote intestinal barrier integrity. Their potential as drug delivery vehicles is significant, enhancing the stability, solubility, and bioavailability of anticancer agents while supporting wound healing and reducing inflammation. Additionally, bovine mEVs exhibit anti-aging properties and protect skin cells from UV damage. As vaccine platforms, mEVs offer advantages including biocompatibility, antigen protection, and the ability to elicit robust immune responses through targeted delivery to specific immune cells. Despite these promising applications, challenges persist, including their complex roles in cancer, effective antigen loading, regulatory hurdles, and the need for standardized production methods. Achieving high targeting specificity and understanding the long-term effects of mEV-based therapies are essential for clinical translation. Ongoing research aims to optimize mEV production methods, enhance targeting capabilities, and conduct rigorous preclinical and clinical studies. By addressing these challenges, mEVs hold the potential to revolutionize vaccine development and targeted drug delivery, ultimately improving therapeutic outcomes across various medical fields.

Potentials of Milk-Derived Extracellular Vesicles As Carriers for Oral Delivery of Active Phytoconstituents

Multifunctional Milk-Derived Small Extracellular Vesicles and Their Biomedical Applications

Extracellular vesicles and exosome-like nanovesicles as pioneering oral drug delivery systems

Milk-Derived Extracellular Vesicles: A Novel Perspective on Comparative Therapeutics and Targeted Nanocarrier Application

The Potential of Milk-Derived Exosomes for Drug Delivery

Milk-Derived Extracellular Vesicles in Inter-Organism, Cross-Species Communication and Drug Delivery

Therapeutic Potential of Bovine Milk-Derived Extracellular Vesicles

Milk Exosomes: an Oral Drug Delivery System with Great Application Potential

Milk-derived small extracellular vesicles: a new perspective on dairy nutrition

Food-derived extracellular vesicles: natural nanocarriers for active phytoconstituents in new functional food

Milk-Derived Extracellular Vesicles: Biomedical Applications, Current Challenges, and Future Perspectives

Cow Milk and Intestinal Epithelial Cell-Derived Extracellular Vesicles as Systems for Enhancing Oral Drug Delivery

Plant-derived extracellular vesicles as oral drug delivery carriers

Oral Administration Properties Evaluation of Three Milk-Derived Extracellular Vesicles Based on Ultracentrifugation Extraction Methods

Milk-derived Exosomes As a Promising Vehicle for Oral Delivery of Hydrophilic Biomacromolecule Drugs

Milk Exosomes Facilitate Oral Delivery of Drugs Against Intestinal Bacterial Infections.

Advanced research on extracellular vesicles based oral drug delivery systems

The Potential of Exosomes From Cow Milk for Oral Delivery

Milk-borne small extracellular vesicles: kinetics and mechanisms of transport, distribution, and elimination

Milk-derived exosomes exhibit versatile effects for improved oral drug delivery

Applications of plant-derived extracellular vesicles in medicine